Endocrinology, Diabetes & Metabolism Case Reports (Jun 2020)

When primary hyperparathyroidism comes as good news

  • Daniela Gallo,
  • Sara Rosetti,
  • Ilaria Marcon,
  • Elisabetta Armiraglio,
  • Antonina Parafioriti,
  • Graziella Pinotti,
  • Giuseppe Perrucchini,
  • Bohdan Patera,
  • Linda Gentile,
  • Maria Laura Tanda,
  • Luigi Bartalena,
  • Eliana Piantanida

DOI
https://doi.org/10.1530/EDM-20-0046
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 6

Abstract

Read online

Brown tumors are osteoclastic, benign lesions characterized by fibrotic stroma, intense vascularization and multinucleated giant cells. They are the terminal expression of the bone remodelling process occurring in advanced hyperparathyroidism. Nowadays, due to earlier diagnosis, primary hyperparathyroidism keeps few of the classical manifestations and brown tumors are definitely unexpected. Thus, it may happen that they are misdiagnosed as primary or metastatic bone cancer. Besides bone imaging, endocrine evaluation including measurement of serum parathyroid hormone and calcium (Ca) levels supports the pathologist to address the diagnosis. Herein, a case of multiple large brown tumors misdiagnosed as a non-treatable osteosarcoma is described, with special regards to diagnostic work-up. After selective parathyroidectomy, treatment with denosumab was initiated and a regular follow-up was established. The central role of multidisciplinary approach involving pathologist, endocrinologist and oncologist in the diagnostic and therapeutic work-up is reported. In our opinion, the discussion of this case would be functional especially for clinicians and pathologists not used to the differential diagnosis in uncommon bone disorders.

Keywords